David Gandara

David Gandara

Company: UC Davis Comprehensive Cancer Center; International Society for Liquid Biopsy

Job title: Professor, Director, Thoracic Oncology Program; Chief Medical Officer

Bio:

David Gandara, Professor of Medicine Emeritus at the University of California, Davis, is Director of Thoracic Oncology and the Senior Advisor to the Director and Director of Thoracic Oncology at UC Davis Comprehensive Cancer Center. He was recently appointed Chief Medical Officer for International Society of Liquid Biopsy (ISLB), a non-profit organization dedicated to advancing the science and clinical application of liquid biopsy in cancer diagnosis and therapy. He is an internationally known clinician-scientist and lung cancer thought leader and has published over 450 peer-reviewed papers. He has led many notable research projects in lung cancer, including early therapeutics trials through an N01-sponsored award, cooperative group trials as past-chair of the SWOG Lung Committee and multi-institutional translational science projects such as clinical director of the patient-derived xenograft (PDX) lung program in collaboration with The Jackson Laboratory Cancer Center. Dr. Gandara has been selected for many awards and honors, including the lifetime Scientific Award from the International Association for Study of Lung Cancer (IASLC), the Team Science Award from the Addario Lung Cancer Foundation and the Trajectory Achievement Award from the ISLB. He is currently principal investigator for a National Cancer Institute UG1 award to UCDCCC for cancer clinical trials, co-leader of Lung MAP, a unique NCI-sponsored public-private partnership for new drug development in lung cancer and is founding co-chair and current member of the NCI-directed Investigational Drug Steering Committee (IDSC). Dr. Gandara is past editor-in-chief of the journal Clinical Lung Cancer. He served as president of the IASLC from 2009-2011 and as treasurer from 2013-2017 and is a prior member of the board of directors and secretary-treasurer of ASCO. In 2017, Gandara received the Giants of Cancer Care Award in lung cancer.

Seminars:

Panel Discussion 1:00 pm

Read more

day: Workshop Agenda: Patient Enrollment Innovative Trends Using a Liquid Biopsy

Presentation 12:35 pm

Read more

day: Workshop Agenda: Patient Enrollment Innovative Trends Using a Liquid Biopsy

Reflecting on the Evolving Role of Liquid Biopsy in Precision Oncology: 2022 & Beyond 8:30 am

• The landscape is changing very quickly, with more entrants into the industry and increasingly promising data being announced on a regular basis • As non-invasive testing comes to fruition, it’s important we recognise how the industry is evolving and identifying where liquid biopsy can permit the more comprehensive study of disease resulting in patient…Read more

day: Day 1 - morning

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.